Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers

被引:216
作者
Anitua, Eduardo [1 ]
Aguirre, Jose J. [1 ]
Algorta, Jaime [2 ]
Ayerdi, Eduardo [3 ]
Cabezas, Ana I. [4 ]
Orive, Gorka [1 ]
Andia, Isabel [1 ]
机构
[1] Inst Biotechnol, Vitoria, Spain
[2] Hosp Txagorritxu, Fdn LEIA, Vitoria, Spain
[3] Hosp Txagorritxu, Serv Traumatol, Vitoria, Spain
[4] Hosp Txagorritxu, Serv Vasc Surg, Vitoria, Spain
关键词
chronic cutaneous ulcers; platelet; growth factors; PRGF; randomized trial;
D O I
10.1002/jbm.b.30886
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Autologous Preparation Rich in Growth Factors (PRGF), a small volume of plasma enriched in platelets, is a novel therapeutic strategy for the acceleration of the wound healing of a wide range of tissues because of the continuous release of multiple growth factors, including PDGF-AB, TGF-beta 1, IGF-I, HGF, VEGF-A, and EGF. In this article, we have characterized the PRGF preparation and designed a randomized open-label controlled pilot trial to evaluate the effectiveness of PRGF in the treatment of chronic cutaneous Ulcers. Results showed that at 8 weeks, the mean percentage of surface healed in the PRGF group was 72.94% +/- 22.25% whereas it was 21.48% +/- 33.56% in the control group (P < 0.05). These results, with the limitations of a pilot study, suggest that topical application of PRGF is more effective than standard therapy in helping a chronic ulcer to heal. (C) 2007 Wiley Periodicals, Inc.
引用
收藏
页码:415 / 421
页数:7
相关论文
共 32 条
[11]   Platelet gel for healing cutaneous chronic wounds [J].
Crovetti, G ;
Martinelli, G ;
Issi, M ;
Barone, M ;
Guizzardi, M ;
Campanati, B ;
Moroni, M ;
Carabelli, A .
TRANSFUSION AND APHERESIS SCIENCE, 2004, 30 (02) :145-151
[12]   Managing the patient with venous ulcers [J].
de Araujo, T ;
Valencia, I ;
Federman, DG ;
Kirsner, RS .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (04) :326-334
[13]   Wound healing: An overview of acute, fibrotic and delayed healing [J].
Diegelmann, RF ;
Evans, MC .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 :283-289
[14]   Wound-healing defects in mice lacking fibrinogen [J].
Drew, AF ;
Liu, H ;
Davidson, JM ;
Daugherty, CC ;
Degen, JL .
BLOOD, 2001, 97 (12) :3691-3698
[15]   Engineered growth factors and cutaneous wound healing: Success and possible questions in the past 10 years [J].
Fu, XB ;
Li, XK ;
Cheng, B ;
Chen, W ;
Sheng, ZY .
WOUND REPAIR AND REGENERATION, 2005, 13 (02) :122-130
[16]  
Ganio C, 1993, J Foot Ankle Surg, V32, P263
[17]  
Goldman Robert, 2004, Adv Skin Wound Care, V17, P24, DOI 10.1097/00129334-200401000-00012
[18]  
Knighton D R, 1988, Prog Clin Biol Res, V266, P319
[19]   A PROSPECTIVE RANDOMIZED TRIAL OF AUTOLOGOUS PLATELET-DERIVED WOUND-HEALING FACTORS FOR TREATMENT OF CHRONIC NONHEALING WOUNDS - A PRELIMINARY-REPORT [J].
KRUPSKI, WC ;
REILLY, LM ;
PEREZ, S ;
MOSS, KM ;
CROMBLEHOLME, PA ;
RAPP, JH .
JOURNAL OF VASCULAR SURGERY, 1991, 14 (04) :526-536
[20]   Effectiveness of recombinant human platelet-derived growth factor for the treatment of diabetic neuropathic foot ulcers [J].
Margolis, DJ ;
Bartus, C ;
Hoffstad, O ;
Malay, S ;
Berlin, JA .
WOUND REPAIR AND REGENERATION, 2005, 13 (06) :531-536